Electrical Impedance Tomography-Derived Flow Index for Predicting Weaning Success and Post-Extubation Outcomes: A Multicenter Prospective Observational Study

NCT ID: NCT06876792

Last Updated: 2026-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-01

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Accurate prediction of readiness to liberate patients from mechanical ventilation remains challenging. Conventional indices such as the rapid shallow breathing index (RSBI) and maximal inspiratory pressure (MIP) often miss early signs of injurious breathing patterns or regional ventilation asynchrony that can lead to extubation failure. Electrical impedance tomography (EIT) provides continuous, non-invasive imaging of regional lung ventilation. We developed a novel EIT-derived Flow Index (FI) which integrates the magnitude of inspiratory effort with the temporal synchrony of lung filling. This prospective, multicenter observational study aimed to (1) validate the predictive value of FI during spontaneous breathing trials (SBT) compared with conventional weaning indices, and (2) investigate the association between FI and pendelluft magnitude as a potential marker of patient self-inflicted lung injury (P-SILI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This multicenter observational study was conducted in three ICUs in China. Adult patients (≥18 years) who received invasive mechanical ventilation for

≥48 hours and met standard criteria for SBT readiness underwent a standardized 30-minute pressure-support SBT (PSV 8 cmH₂O, PEEP 5 cmH₂O, FiO₂ ≤0.5). Continuous EIT recordings were performed to calculate global and regional FI from pixel-level inspiratory flow-time curves. Pendelluft magnitude was quantified as the percentage of intrapulmonary gas redistribution during inspiration. Conventional indices (RSBI, MIP, P0.1, NIF) and physiological variables were recorded. Primary Endpoint: SBT success (completion without respiratory distress, desaturation, or hemodynamic instability).

Secondary Endpoints:

* Reintubation within 48 h
* Weaning failure
* Ventilator-free days at day 7
* ICU mortality Predictive accuracy was evaluated via ROC analysis in training (n=90) and validation (n=60) cohorts.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Drive Acute Respiratory Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional method Respiratory Drive group

Conventional method Respiratory Drive group(Methods include: esophageal pressure monitoring, airway obstruction pressure (P0.1) )

electrical impedance tomography

Intervention Type DEVICE

Respiratory drive assessed by flow index measured by electrical impedance tomography.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

electrical impedance tomography

Respiratory drive assessed by flow index measured by electrical impedance tomography.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years
* Acute respiratory failure requiring intubation and mechanical ventilation ≥48 hours
* Hemodynamic stability (no escalation of vasoactive agents)
* Oxygenation: FiO₂ ≤0.5, PEEP ≤8 cmH₂O
* Meeting standard ICU criteria for SBT readiness

Exclusion Criteria

* Neuromuscular diseases impairing spontaneous breathing
* High cervical spinal cord injury
* Deep sedation (RASS ≤-3)
* Inadequate EIT signal quality
* Contraindications to EIT (e.g., implanted cardiac devices)
* Pregnancy
* Expected survival \<24 h
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Rui Jin Hospital

UNKNOWN

Sponsor Role collaborator

Foshan Hospital of Traditional Chinese Medicine

OTHER

Sponsor Role collaborator

Fujian Provincial Hospital

OTHER

Sponsor Role collaborator

Ruijin Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hongping Qu

Role: STUDY_CHAIR

Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

Jialin Liu

Role: STUDY_DIRECTOR

Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

rui zhang

Role: PRINCIPAL_INVESTIGATOR

Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

Site Status

Fujian Provincial Hospital

Fuzhou, Fujian, China

Site Status

Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China.

Shanghai, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202530

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.